Citadel Advisors
BPTH

Citadel Advisors’s Bio-Path Holdings Inc BPTH Stock Holding History

Citadel Advisors’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,917
Closed -$9.93K – 15794
2024
Q3 		$9.93K Buy
+10,917
New +$15K ﹤0.01% 13230
2024
Q1 		– Sell
-1,210
Closed -$11.2K – 15783
2023
Q4 		$11.2K Buy
+1,210
New +$12.7K ﹤0.01% 13053
2023
Q2 		– Sell
-1,773
Closed -$49.3K – 15518
2023
Q1 		$49.3K Buy
1,773
+784
+79% +$28.2K ﹤0.01% 12162
2022
Q4 		$29.9K Buy
989
+444
+81% +$19.4K ﹤0.01% 12759
2022
Q3 		$35K Buy
+545
New +$41.4K ﹤0.01% 11830
2021
Q4 		– Sell
-620
Closed -$64K – 15054
2021
Q3 		$64K Sell
620
-648
-51% -$77.7K ﹤0.01% 13228
2021
Q2 		$169K Buy
1,268
+238
+23% +$29.3K ﹤0.01% 12368
2021
Q1 		$145K Buy
+1,030
New +$122K ﹤0.01% 12089
2018
Q4 		– Sell
-33
Closed -$8K – 9913
2018
Q3 		$8K Buy
+33
New +$17.8K ﹤0.01% 9119
2016
Q3 		– Sell
-8
Closed -$64K – 7912
2016
Q2 		$64K Buy
8
+3
+60% +$30.4K ﹤0.01% 6347
2016
Q1 		$51K Buy
+5
New +$32.4K ﹤0.01% 6244
2015
Q2 		– Sell
-3
Closed -$22K – 9182
2015
Q1 		$22K Buy
+3
New +$25.2K ﹤0.01% 7850

Other funds holding BPTH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citadel Advisors's BPTH Position: Q4 2024 in Review

Citadel Advisors sold out of Bio-Path Holdings Inc (BPTH) in Q4 2024, closing a stake of 10,917 shares — an estimated $9.93K sold.

Citadel Advisors first reported a position in BPTH in Q1 2015 and held it in 12 quarters. The position peaked at $169K in Q2 2021. 22 funds tracked by Wall St. Rank hold BPTH as of Q4 2024.

  • Citadel Advisors reported no remaining Bio-Path Holdings Inc position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 10,917 Bio-Path Holdings Inc shares in Q4 2024, an estimated $9.93K.
  • Citadel Advisors first reported a position in Bio-Path Holdings Inc in Q1 2015 and held it in 12 quarters.
  • Citadel Advisors's Bio-Path Holdings Inc position peaked at $169K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.